DAFNA Capital Management’s PhaseBio Pharmaceuticals, Inc. Common Stock PHAS Stock Holding History

Quarter	Market Value	Status	Shares	Shares Change %	Trade Value	Portfolio Weight	Portfolio Position
2023 Q1	–	Sell	-321,856	Closed	-$9.69K	–	83
2022 Q4	$9.69K	Hold	321,856	–	–	﹤0.01%	79
2022 Q3	$57K	Sell	321,856 -56,755	-15%	-$10.1K	0.02%	87
2022 Q2	$227K	Hold	378,611	–	–	0.06%	84
2022 Q1	$500K	Hold	378,611	–	–	0.13%	82
2021 Q4	$988K	Sell	378,611 -224,431	-37%	-$586K	0.25%	64
2021 Q3	$1.88M	Hold	603,042	–	–	0.5%	52
2021 Q2	$2.24M	Hold	603,042	–	–	0.47%	45
2021 Q1	$2.09M	Buy	603,042 +282,500	+88%	+$978K	0.5%	48
2020 Q4	$1.08M	Hold	320,542	–	–	0.32%	58
2020 Q3	$1.13M	Hold	320,542	–	–	0.37%	54
2020 Q2	$1.47M	Hold	320,542	–	–	0.43%	46
2020 Q1	$1.06M	Sell	320,542 -40,000	-11%	-$132K	0.44%	46
2019 Q4	$2.2M	Hold	360,542	–	–	0.76%	32
2019 Q3	$1.5M	Buy	360,542 +160,529	+80%	+$669K	0.57%	46
2019 Q2	$2.62M	Buy	200,013 +127,513	+176%	+$1.67M	0.99%	29
2019 Q1	$689K	Sell	72,500 -27,500	-28%	-$261K	0.3%	60
2018 Q4	$309K	Buy	+100,000	New	+$309K	0.15%	71